Shen Fu

1.3k total citations
44 papers, 1.0k citations indexed

About

Shen Fu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shen Fu has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shen Fu's work include Prostate Cancer Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shen Fu is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shen Fu collaborates with scholars based in China, United States and South Korea. Shen Fu's co-authors include Wei‐Xiang Qi, Xiaomao Guo, Zhangru Yang, Jin Meng, Qing Zhang, Qing Zhang, Ping Li, Jin Meng, Qing Zhang and Bingxin Li and has published in prestigious journals such as Annals of Surgery, International Journal of Radiation Oncology*Biology*Physics and BioMed Research International.

In The Last Decade

Shen Fu

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shen Fu China 20 346 334 252 216 182 44 1.0k
Rumi Murata Japan 18 313 0.9× 349 1.0× 356 1.4× 175 0.8× 311 1.7× 33 966
Ji Hyun Chang South Korea 19 201 0.6× 298 0.9× 299 1.2× 361 1.7× 243 1.3× 85 1.1k
Pedram Heidari United States 20 264 0.8× 210 0.6× 162 0.6× 298 1.4× 315 1.7× 77 1.1k
Chun‐Ming Huang Taiwan 23 485 1.4× 308 0.9× 171 0.7× 796 3.7× 157 0.9× 58 1.7k
Amarnath Challapalli United Kingdom 15 170 0.5× 258 0.8× 221 0.9× 171 0.8× 368 2.0× 59 816
Arif N. Ali United States 14 134 0.4× 221 0.7× 125 0.5× 154 0.7× 150 0.8× 27 664
Edgar Ben‐Josef United States 19 324 0.9× 973 2.9× 176 0.7× 408 1.9× 339 1.9× 34 1.6k
June‐Key Chung South Korea 24 235 0.7× 312 0.9× 242 1.0× 328 1.5× 704 3.9× 58 1.4k
Mark Thalgott Germany 21 252 0.7× 758 2.3× 220 0.9× 324 1.5× 284 1.6× 38 1.2k
Wengui Xu China 18 225 0.7× 423 1.3× 179 0.7× 335 1.6× 420 2.3× 91 1.1k

Countries citing papers authored by Shen Fu

Since Specialization
Citations

This map shows the geographic impact of Shen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shen Fu more than expected).

Fields of papers citing papers by Shen Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shen Fu. The network helps show where Shen Fu may publish in the future.

Co-authorship network of co-authors of Shen Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Shen Fu. A scholar is included among the top collaborators of Shen Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shen Fu. Shen Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ping, et al.. (2022). Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study. Frontiers in Oncology. 11. 808216–808216. 4 indexed citations
2.
Li, Ping, Shuang Wu, Guangyuan Zhang, et al.. (2021). Combination of 99mTc-Labeled PSMA-SPECT/CT and Diffusion-Weighted MRI in the Prediction of Early Response After Carbon Ion Therapy in Prostate Cancer: A Non-Randomized Prospective Pilot Study. Cancer Management and Research. Volume 13. 2191–2199. 3 indexed citations
3.
Chen, Xue, Qi Yu, Ping Li, & Shen Fu. (2021). Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research. Frontiers in Oncology. 11. 760752–760752. 5 indexed citations
4.
Zhang, Yafang, Ping Li, Qi Yu, et al.. (2019). Preliminary exploration of clinical factors affecting acute toxicity and quality of life after carbon ion therapy for prostate cancer. Radiation Oncology. 14(1). 94–94. 15 indexed citations
5.
Wu, Shuang, Yafang Zhang, Xuhua Ren, et al.. (2019). <p>Imaging-Based Individualized Response Prediction Of Carbon Ion Radiotherapy For Prostate Cancer Patients</p>. Cancer Management and Research. Volume 11. 9121–9131. 15 indexed citations
6.
Zhao, Ning, et al.. (2016). RGD-conjugated mesoporous silica-encapsulated gold nanorods enhance the sensitization of triple-negative breast cancer to megavoltage radiation therapy. International Journal of Nanomedicine. Volume 11. 5595–5610. 41 indexed citations
7.
Meng, Dan, Yang Liu, Shen Fu, et al.. (2016). Environment Assessing for Airborne Radioactive Particulate Release-introduction of Methods in IAEA Safety Report Series No.19. Journal of Radiation Protection and Research. 41(4). 409–417. 1 indexed citations
8.
Qi, Wei‐Xiang, Qing Zhang, Ping Li, et al.. (2016). The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC). Journal of Cancer Research and Clinical Oncology. 142(6). 1361–1367. 9 indexed citations
9.
Qi, Wei‐Xiang, Shen Fu, Qing Zhang, & Xiaomao Guo. (2016). Incidence and risk of hypertension associated with ramucirumab in cancer patients: A systematic review and meta-analysis. Journal of Cancer Research and Therapeutics. 12(2). 775–781. 9 indexed citations
10.
Yang, Zhangru, Ning Zhao, Jin Meng, et al.. (2016). Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes. Oncotarget. 7(18). 26422–26435. 27 indexed citations
11.
Qi, Wei‐Xiang, Shen Fu, Qing Zhang, & Xiaomao Guo. (2015). Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials. Critical Reviews in Oncology/Hematology. 94(3). 323–336. 23 indexed citations
12.
Meng, Jin, Ping Li, Qing Zhang, Zhangru Yang, & Shen Fu. (2014). A four-long non-coding RNA signature in predicting breast cancer survival. Journal of Experimental & Clinical Cancer Research. 33(1). 84–84. 130 indexed citations
13.
14.
Qi, Wei‐Xiang, Shen Fu, Qing Zhang, & Xiaomao Guo. (2014). Bevacizumab Increases the Risk of Severe Congestive Heart Failure in Cancer Patients: An Up-to-Date Meta-Analysis with a Focus on Different Subgroups. Clinical Drug Investigation. 34(10). 681–690. 31 indexed citations
15.
Zhang, Qing, et al.. (2014). Benefits from adjuvant intraoperative radiotherapy treatment for gastric cancer: A meta-analysis. Molecular and Clinical Oncology. 3(1). 185–189. 8 indexed citations
16.
Qi, Wei‐Xiang, et al.. (2014). Risk of gastrointestinal perforation in cancer patients treated with aflibercept: a systematic review and meta-analysis. Tumor Biology. 35(11). 10715–10722. 19 indexed citations
18.
Fu, Shen, Jiade J. Lu, Qing Zhang, et al.. (2008). Intraoperative Radiotherapy Combined With Adjuvant Chemoradiotherapy for Locally Advanced Gastric Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 72(5). 1488–1494. 21 indexed citations
19.
Fu, Shen. (2006). Efficacy of Amifostine on Patients with Head and Neck Squamous Cell Carcinomas Undergoing Radiation Therapy and Chemotherapy and Clinical Observation on Its Hematologic Toxicity. Zhongguo yaofang. 2 indexed citations
20.
Fu, Shen, et al.. (1994). [Hyperfractionated irradiation for non-small cell lung cancer (NSCLC)--a phase III clinical trial].. PubMed. 16(4). 306–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026